Mobile Heart Monitor Maker AliveCor Taps Former Google Exec Vic Gundotra as CEO
AliveCor, which makes a smartphone-connected heart monitor, plans to announce Wednesday it has hired former Google executive Vic Gundotra as chief executive. — AliveCor — Gundotra, who left Google last year …
Context & Ripple Effects
AliveCor's smartphone-connected heart monitor was a hardware niche play until the company hired Vic Gundotra away from Google as chief executive in November 2015 — a bet on consumer-software DNA running a medical device company. The subsequent coverage shows what that bet produced: within months, Gundotra's AliveCor was building a heart monitor band for the Apple Watch while awaiting FDA approval, and by 2017 it had unveiled an AI platform to flag abnormal heart conditions, backed by $30M led by Omron Healthcare.
The Gundotra era also set up his own succession arc: after shipping the six-lead KardiaMobile 6L with FDA clearance, he stepped down as CEO in January 2019, staying on the board while the company turned to Priya Abani, a former Amazon Alexa director, as its next leader.
First-order effects
- Gundotra inherits an FDA-regulated hardware startup and immediately points it toward consumer platforms — the Apple Watch band announced in March 2016 is the first visible output of the hire.
Second-order effects
- Omron Healthcare's $30M round behind the 2017 AI-platform launch, later followed by its lead of the $65M Series E, ties a Japanese healthcare incumbent to AliveCor's algorithm roadmap — capital following the shift from single devices to software-flagged diagnostics.
Third-order effects
- The pattern holds across leadership changes: ex-Google, then ex-Amazon-Alexa executives cycling through the CEO seat signals consumer-health device makers consolidating around big-tech product talent, with algorithms rather than hardware as the durable asset.
The trend: Consumer-health hardware startups are recruiting big-tech product leaders and layering diagnostic algorithms over their devices, turning one-off monitors into platform businesses backed by strategic healthcare investors like Omron.